C-Myc (EQKLISEEDL)-FITC Antibody [Polyclonal]

The C-Myc (EQKLISEEDL)-FITC Antibody is a premium polyclonal antibody conjugated with fluorescein isothiocyanate (FITC), designed to specifically detect the C-Myc epitope tag. Widely used in molecular biology, the C-Myc tag facilitates the detection, purification, and localization of recombinant proteins. The FITC conjugation enables direct fluorescent detection, making it ideal for a variety of applications including flow cytometry, immunofluorescence, and confocal microscopy.

This antibody is optimized for reliable detection of C-Myc-tagged proteins in a range of expression systems and is suitable for high-sensitivity studies in both basic and applied research.

Key Features

  1. Epitope Targeting: Recognizes the highly specific EQKLISEEDL sequence of the C-Myc tag.
  2. Fluorescent Labeling: Conjugated with FITC, a bright and photostable fluorophore with excitation/emission maxima at 495/519 nm, producing sharp green fluorescence.
  3. Polyclonal Design: Detects multiple epitopes, enhancing sensitivity and reducing false negatives.
  4. Versatile Applications: Compatible with immunofluorescence (IF), flow cytometry (FC), confocal microscopy, and immunoprecipitation (IP).
  5. Cross-Species Compatibility: Reacts with C-Myc-tagged proteins across human, mouse, bacterial, and yeast systems.

Specifications

Attribute Details
Host Species Rabbit
Isotype IgG
Conjugate FITC (Fluorescein Isothiocyanate)
Epitope Recognized C-Myc Tag Sequence (EQKLISEEDL)
Concentration 0.1 mg/mL
Applications IF, FC, IP, Confocal Microscopy
Storage Conditions Store at 4°C in the dark
Formulation PBS, pH 7.4, with 0.09% sodium azide and 50% glycerol

Applications

1. Immunofluorescence (IF)

  • Objective: Detect C-Myc-tagged proteins within fixed cells or tissues.
  • Protocol:
    1. Fix samples in 4% paraformaldehyde for 10-15 minutes.
    2. Permeabilize with 0.1% Triton X-100 for 10 minutes.
    3. Block nonspecific binding with 5% BSA or serum for 30 minutes.
    4. Incubate with the C-Myc-FITC Antibody (1:100 dilution) for 1 hour at room temperature.
    5. Wash, counterstain with DAPI for nuclei, and mount for imaging.

2. Flow Cytometry (FC)

  • Objective: Quantify expression of C-Myc-tagged proteins in cell populations.
  • Protocol:
    1. Prepare single-cell suspensions and fix cells using a flow-compatible buffer.
    2. Incubate with the antibody (1:50 dilution) for 30 minutes on ice.
    3. Wash and analyze on a flow cytometer equipped with a 488 nm laser.

3. Confocal Microscopy

  • Objective: High-resolution visualization of C-Myc-tagged protein localization within cells.
  • Protocol:
    • Use the immunofluorescence protocol, and ensure optimal imaging settings for FITC fluorescence.

4. Immunoprecipitation (IP)

  • Objective: Enrich C-Myc-tagged proteins for functional or structural analysis.
  • Protocol:
    1. Add antibody to lysates containing C-Myc-tagged proteins and incubate overnight at 4°C.
    2. Add protein A/G beads to capture the immune complex.
    3. Wash beads to remove nonspecific proteins, then elute bound protein for analysis.

5. Western Blot Validation

  • Objective: Confirm C-Myc expression using fluorescence instead of HRP.
  • Protocol:
    • Run SDS-PAGE and transfer to a PVDF membrane.
    • Use the FITC-antibody directly for fluorescence-based detection.

Research Applications

  1. Protein Expression Studies: Track recombinant protein expression and localization.
  2. Drug Screening: Quantify the effects of small molecules on tagged proteins.
  3. Molecular Interaction Assays: Investigate protein-protein or protein-DNA interactions.
  4. Cell Biology: Visualize and quantify subcellular localization and trafficking of tagged proteins.
  5. High-Throughput Screening: Ideal for assays requiring rapid fluorescence detection.

Advantages

  1. Direct Detection: No need for secondary antibodies, reducing assay time.
  2. Bright Fluorescence: FITC provides excellent signal strength and photostability.
  3. Wide Compatibility: Suitable for use with various recombinant protein systems.
  4. Cost-Effective: Saves time and resources in fluorescent labeling and detection.

Storage and Handling

  • Storage: Store at 4°C in the dark to prevent photobleaching.
  • Stability: Stable for 6 months when stored properly. For long-term use, aliquot and avoid freeze-thaw cycles.

Safety Information

  • Contains sodium azide as a preservative. Use personal protective equipment when handling and dispose of waste properly.

References

  1. PubMed: C-Myc Research Articles
  2. KEGG Pathways: C-Myc Signaling Pathways
  3. NIH: Protein Expression Resources
  4. Addgene: C-Myc Plasmids and Tools

Human Interleukin-2 Receptor Subunit Alpha ELISA [IL2RA]: A Comprehensive Overview

The Human Interleukin-2 Receptor Subunit Alpha (IL2RA), also known as CD25, is a key component of the interleukin-2 (IL-2) receptor complex. This molecule is essential for regulating immune cell function and maintaining immune system balance. The IL2RA ELISA kit has become a critical tool in both research and clinical diagnostics, enabling precise quantification of soluble IL2RA (sIL2RA) levels in various biological samples.

IL2RA: A Cornerstone of Immune Regulation

IL2RA binds to interleukin-2, a cytokine critical for T cell proliferation, differentiation, and survival. It is expressed in both membrane-bound and soluble forms. While the membrane-bound form is predominantly found on activated T cells and regulatory T cells (Tregs), the soluble form is released during immune activation and acts as a biomarker in numerous diseases.

For detailed information on the IL2-IL2RA signaling pathway, visit the National Cancer Institute (NCI) or NCBI.

Role of IL2RA in Health and Disease

1. Immune System Balance
IL2RA is vital for maintaining immune homeostasis by modulating the activity of Tregs, which prevent autoimmune reactions. Dysfunction in IL2RA signaling can lead to immune system hyperactivity, as discussed by the National Institute of Allergy and Infectious Diseases (NIAID).

2. Autoimmune Diseases
Increased sIL2RA levels are a hallmark of autoimmune diseases such as lupus, rheumatoid arthritis, and multiple sclerosis. Studies from the National Institutes of Health (NIH) have explored the potential of IL2RA as a diagnostic and prognostic marker for these conditions.

3. Cancer Biology
IL2RA is overexpressed in certain cancers, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and adult T-cell leukemia/lymphoma. Research from the American Cancer Society (ACS) highlights its role in tumor immune evasion and as a target for immunotherapy.

4. Transplantation
Soluble IL2RA is a marker of immune activation in transplant patients and can predict rejection episodes. Guidelines from the United Network for Organ Sharing (UNOS) emphasize its importance in post-transplant care.

IL2RA ELISA: Features and Benefits

  1. High Specificity and Sensitivity
    The IL2RA ELISA kit is designed to detect low concentrations of sIL2RA with high precision, as supported by validation studies from NIH.
  2. Wide Dynamic Range
    The assay accommodates a broad range of sIL2RA concentrations, making it suitable for samples from both healthy individuals and patients with pathological conditions [PubMed].
  3. Robust and Reproducible
    Manufactured under stringent quality control measures, the kit delivers consistent results, adhering to ISO standards for clinical diagnostics [FDA].
  4. User-Friendly Protocols
    The ELISA kit includes optimized reagents and a step-by-step protocol, simplifying workflows for both novice and experienced researchers [CDC].

Research Applications

  1. Biomarker Discovery
    IL2RA is widely used in biomarker research to identify signatures of immune activation. The National Science Foundation (NSF) supports studies investigating its utility in precision medicine.
  2. Drug Development
    Pharmaceutical companies utilize IL2RA assays to evaluate immunomodulatory effects of drugs, including IL2-based therapies. For more on therapeutic developments, visit the FDA.
  3. Clinical Diagnostics
    sIL2RA levels are used to diagnose and monitor autoimmune diseases, cancers, and transplant rejection. Guidelines from the World Health Organization (WHO) underscore its relevance in diagnostic workflows.

Technical Insights

  • Sensitivity: Detects sIL2RA levels as low as 1 pg/mL in serum or plasma samples [NCBI].
  • Cross-Reactivity: Minimal cross-reactivity ensures accurate measurement in complex biological matrices [NIH].
  • Assay Time: The assay is completed within 2–3 hours, making it suitable for high-throughput applications [FDA].

For a detailed protocol, refer to resources from the Centers for Disease Control and Prevention (CDC).

Future Directions

  • Therapeutic Targeting
    Anti-CD25 monoclonal antibodies, such as daclizumab, are being developed to modulate IL2RA activity in autoimmune diseases and cancers [PubMed].
  • Personalized Medicine
    Measuring sIL2RA levels is paving the way for personalized treatment strategies in transplant immunology and oncology [NIH].
  • Next-Generation ELISAs
    Advances in ELISA technology, including multiplex assays, aim to provide simultaneous quantification of multiple immune biomarkers, improving diagnostic accuracy [NSF].

Conclusion

The Human IL2RA ELISA kit is an invaluable tool in immunological research and clinical diagnostics. Its precision, sensitivity, and versatility make it a preferred choice for studying immune responses and developing targeted therapies. As research progresses, IL2RA continues to reveal its significance in health and disease.

Explore additional resources at:

These links provide comprehensive insights into IL2RA’s role and applications in modern science.

Glut1 Polyclonal Antibody: Essential for Glucose Transport Research

The Glut1 Polyclonal Antibody is an indispensable tool for investigating glucose transport and metabolism in various physiological and pathological conditions. Glucose transporter 1 (Glut1), encoded by the SLC2A1 gene, is a vital protein responsible for facilitating glucose transport across the plasma membrane. This protein plays a critical role in cellular energy metabolism, particularly in tissues with high glucose demands like the brain, erythrocytes, and cancer cells.

The Role of Glut1 in Cellular Physiology

Glut1 is widely expressed and is especially crucial in cells that rely heavily on glucose for energy production. It is upregulated in numerous cancers, where it supports the increased metabolic demands of rapidly proliferating cells. Additionally, Glut1 is a key player in the blood-brain barrier, enabling glucose transport to the central nervous system (CNS) [NCBI.nih.gov]. Defects in Glut1 expression or function are associated with conditions like Glut1 deficiency syndrome, characterized by seizures, developmental delay, and movement disorders [Genetics.nih.gov].

Applications of Glut1 Polyclonal Antibody

  1. Immunohistochemistry (IHC):
    • Used to study Glut1 expression in tissue sections, particularly in cancer research and brain studies [NCI.Cancer.gov].
  2. Western Blotting:
    • Enables quantification of Glut1 protein levels in various cell types and experimental conditions [NIAID.nih.gov].
  3. Flow Cytometry:
    • Facilitates the analysis of Glut1 expression on the surface of live cells, critical for studying metabolic adaptations in immune cells [CDC.gov].
  4. Immunoprecipitation:
    • Useful for isolating Glut1 protein complexes to study its interaction partners in cellular signaling pathways [NIGMS.nih.gov].

Glut1 in Disease Research

Cancer:
Overexpression of Glut1 has been documented in various cancers, including breast, colorectal, and lung cancers. This overexpression supports aerobic glycolysis (Warburg effect), a hallmark of cancer metabolism [Cancer.gov]. Researchers use the Glut1 Polyclonal Antibody to analyze the protein’s role in tumor progression and potential therapeutic targeting.

Neurodegenerative Disorders:
Glut1’s role in the blood-brain barrier makes it a significant focus in studying diseases like Alzheimer’s and Parkinson’s, where glucose metabolism is disrupted [NINDS.nih.gov].

Infectious Diseases:
Glut1 has also been implicated in viral infections, including HIV, where it is involved in the metabolic reprogramming of infected cells [NIH.gov].

Selecting a High-Quality Glut1 Polyclonal Antibody

When choosing a Glut1 Polyclonal Antibody, it is essential to consider factors like:

  • Specificity: Validation against recombinant Glut1 protein to ensure minimal cross-reactivity.
  • Sensitivity: Ability to detect low levels of Glut1 in samples.
  • Application Suitability: Compatibility with multiple experimental techniques like IHC, Western blotting, and flow cytometry [FDA.gov].

Resources for Further Exploration

For more detailed information on Glut1 and its role in health and disease, the following resources provide valuable insights:

  1. National Institutes of Health (NIH): [NIH.gov]
  2. National Cancer Institute (NCI): [NCI.Cancer.gov]
  3. U.S. National Library of Medicine: [NLM.NIH.gov]
  4. National Institute of Neurological Disorders and Stroke (NINDS): [NINDS.nih.gov]
  5. Centers for Disease Control and Prevention (CDC): [CDC.gov]
  6. National Institute of Allergy and Infectious Diseases (NIAID): [NIAID.nih.gov]

Conclusion

The Glut1 Polyclonal Antibody is a versatile and powerful tool for exploring glucose transport mechanisms and their implications in health and disease. Whether investigating cancer metabolism, neurological disorders, or infectious diseases, this antibody provides critical insights into Glut1’s role. By employing this antibody in various assays, researchers can contribute to a deeper understanding of cellular energy metabolism and develop novel therapeutic strategies.

VERIGENE Blood Culture & Gram-Negative PCR Panel Quality Control

The VERIGENE® Blood Culture & Gram-Negative PCR Panel is a sophisticated diagnostic tool designed for the rapid identification of gram-negative bacterial pathogens directly from positive blood cultures. This technology plays a crucial role in diagnosing sepsis and other serious infections, allowing healthcare providers to act quickly in life-threatening situations. The quality control (QC) of such diagnostic panels is paramount in ensuring accuracy and reliability, particularly in clinical laboratories.

The Importance of Blood Cultures in Gram-Negative Infections

Blood cultures remain a key method for detecting bloodstream infections caused by gram-negative bacteria, which are often responsible for severe infections in hospital settings. Traditional culture methods take time, which can delay the initiation of appropriate therapy. The Centers for Disease Control and Prevention (CDC) emphasizes the importance of early and accurate diagnosis of bloodstream infections to improve patient outcomes. The VERIGENE® system offers a faster turnaround time for identifying gram-negative bacteria, thus improving the speed of appropriate therapeutic interventions.

Role of PCR in the VERIGENE® System

The VERIGENE® panel uses polymerase chain reaction (PCR) technology to detect bacterial DNA directly from positive blood cultures. PCR amplification allows for the rapid identification of specific pathogens, reducing the time needed to start targeted treatment. According to the National Institutes of Health (NIH), PCR methods are widely regarded as the gold standard for molecular diagnostics in infectious diseases. The technology behind VERIGENE® significantly shortens the time to diagnosis compared to conventional methods.

Quality Control in Diagnostic Testing

Quality control is crucial in maintaining the accuracy of the VERIGENE® system. Clinical labs must adhere to stringent QC protocols to verify that the diagnostic tool consistently detects the targeted gram-negative pathogens. The Food and Drug Administration (FDA) regulates in vitro diagnostics, including systems like VERIGENE®, to ensure they meet safety and performance standards. Moreover, the Clinical and Laboratory Standards Institute (CLSI) provides detailed guidelines for laboratories to follow in implementing and maintaining quality control.

Pathogens Detected by the VERIGENE® Gram-Negative PCR Panel

The VERIGENE® panel is designed to detect a variety of clinically significant gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Infections caused by these pathogens are associated with significant morbidity and mortality, especially in healthcare settings. The National Library of Medicine (NLM) offers numerous resources on the prevalence and treatment of gram-negative bacterial infections, underscoring the importance of rapid and accurate detection.

Regulatory and Quality Control Guidelines

Proper QC measures are essential for maintaining the reliability of diagnostic systems. The U.S. Department of Health and Human Services (HHS) provides guidelines on laboratory best practices, including the use of control materials to validate test results. Regular validation ensures that diagnostic results are consistent and accurate, preventing errors that could have serious clinical consequences.

Applications in Antimicrobial Stewardship

The rapid identification of gram-negative pathogens through the VERIGENE® system supports antimicrobial stewardship programs by helping to reduce the inappropriate use of broad-spectrum antibiotics. According to the Infectious Diseases Society of America (IDSA), antimicrobial stewardship is critical for preventing the emergence of antibiotic resistance, a major public health concern. Quality control in systems like VERIGENE® ensures that healthcare providers can trust the results when deciding on targeted therapies.

Public Health Implications

Gram-negative bacterial infections are a growing concern, particularly due to the rise of multidrug-resistant strains. The World Health Organization (WHO) and the CDC have identified antimicrobial resistance in gram-negative bacteria as a significant threat to public health. The VERIGENE® system, backed by stringent quality control, is a critical tool in detecting these pathogens and aiding in the appropriate management of infections.

Benefits of Rapid Pathogen Detection

By rapidly identifying gram-negative pathogens, the VERIGENE® system shortens the time to appropriate antibiotic therapy, which is vital in managing infections that can escalate to sepsis. The National Institute of Allergy and Infectious Diseases (NIAID) highlights that early intervention in sepsis cases can save lives, making rapid diagnostic tools like VERIGENE® an indispensable part of modern medical practice.

Conclusion

The VERIGENE® Blood Culture & Gram-Negative PCR Panel offers a reliable and rapid method for identifying serious gram-negative bacterial infections, supported by rigorous quality control measures. By ensuring accuracy through well-established QC protocols, clinical laboratories can trust the results produced by this system. The integration of PCR technology in diagnostics, combined with robust regulatory oversight by the FDA, ensures that systems like VERIGENE® contribute effectively to improved patient outcomes and support global efforts in infection control.

Cusabio Hormone Recombinants

Cusabio Hormone Recombinants

Description

Recombinant human GHR is an active protein expressed from mammalian cells, with a C-terminal MFC-Avi tag. Its expression region is the DNA fragment encoding amino acid residues 27-264 of the human GHR protein. The purity of this GHR protein is greater than 95% as measured by SDS-PAGE. This recombinant Hormone GHR protein migrated to the band with a molecular weight of approximately 67 kDa on the gel. Its endotoxin level is less than 1.0 EU/ug determined by the LAL method. And its bioactivity has been validated in ELISA. In functional ELISA, this Biotinylated human GHR binds to human GH1, with a constant EC50 of 2067-3208 ng/ml. This biotinylated GHR protein could be used to isolate GHR antibodies from samples for further analysis with high sensitivity. It is in stock now.

GHR, a dimeric amino acid receptor, is widely expressed on GH target cells. The GH-GHR-IGF1 axis plays important roles in somatic growth, including cell proliferation, differentiation, division, cell cycle control, immunity, and survival. Aberrations in GHR signalling have been linked to various diseases and chronic conditions such as cancer, ageing, and inflammation.

Purity: greater than 95% as determined by SDS-PAGE.

Endotoxin: Less than 1.0 EU/ug as determined by the LAL method.

Activity

Measured by its binding capacity in a functional ELISA. Immobilized human GH1 (CSB-MP009407HU) at 2 µg/ml can bind to biotinylated human GHR, the EC50 is 2.067-3.208 ng/ml.

Destination Names: GHR

Uniprot No.: P10912

Alternative Names: (GH-binding protein)(GHBP)(serum-binding protein)

Species: Homo sapiens (Human)

Source: Mammalian cell

Expression region: 27-264aa

Mole Weight: 56.6

Protein length: Partial

Tag information: C-terminal MFC-Avi-tagged

Form: Lyophilized powder

Note: We will preferably ship the format we have in stock, however, if you have any special requirements for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Buffer: Lyophilized from 0.2 μm filtered PBS, 6% trehalose, pH 7.4

Reconstitution

We recommend that this vial be briefly centrifuged before opening to bring the contents to the bottom. Reconstitute protein in sterile deionized water at a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and an aliquot for long-term storage at -20°C/-80°C. Our final default glycerol concentration is 50%. Customers could use it for reference.

Storage Conditions

Store at -20°C/-80°C upon receipt, need to be aliquoted for multiple uses. Avoid repeated cycles of freezing and thawing.

Shelf life

Shelf life is related to many factors, storage condition, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.

Delivery time: 3-7 business days

Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Recombinant hormones

The hormone is a kind of biochemical substance produced by multicellular glands and then transported by the circulatory system to the target organ to coordinate its physiology and behaviour. Hormones function as a serious form of communication between different organs and tissues. Hormones regulate a variety of physiological and behavioural activities, as well as digestion, metabolism, respiration, tissue function, etc. Hormones deliberately affect the target tissue by binding to specific receptor proteins and causing a specific action on the target cell. When a hormone binds to the receptor protein, it results in the activation of a signal transduction mechanism.

Ultimately, this leads to cell-type-specific genomic responses that cause the hormone to activate genes that regulate protein synthesis. Hormones can be divided into two categories: water-soluble and fat-soluble. In the first category, like protein hormones and catecholamines, they are water-soluble and therefore easily transported through the circulatory system. The next category, like steroid and thyroid hormones, are fat-soluble. For their distribution, they must bind to carrier plasma glycoproteins to form ligand-protein complexes.

BiologicsCorp(BIC) mainly manufactures two types of hormones: parathyroid hormone (PTH) and exedin. Expedia is a hormone discovered from lizard venom, it plays a role in enhancing glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying in vivo, and this will be helpful in reducing the weight. PTH increases the concentration of calcium in the blood.

Cusabio Cell differentiation Recombinants

Cusabio Cell differentiation Recombinants

Cellular differentiation determines cell fate

Cell differentiation Recombinants is the process in which a cell changes from one type to many different types. In the process of cell differentiation, there are differences in morphological structure and physiological function. All organisms start from a single cell. For example, humans derive from fertilized eggs, and this process involves the differentiation of embryonic stem cells. Cellular differentiation occurs throughout life. For example, hematopoietic stem cells differentiate into various immune cells. The abnormal differentiation of cells can lead to cancer cells. Cancer cells divide indefinitely, forming tumours and endangering human health.

 

Cellular differentiation involves a variety of signal transduction processes:

1. MAPK signalling pathway

2. Phosphatidylinositol (PLC) signalling pathway

3. cAMP/PKA signalling pathway

4. Via JAK-STAT

5. PI3K-AKT-mTOR signalling pathway

6. Wnt signalling pathway

7. TGF-β Superfamily Signaling Pathway

1. MAPK signalling pathway

MAPK is a mitogen-activated protein kinase, a class of protein kinases with dual phosphorylation of serine and tyrosine in the cytosol. The MAPK signalling pathway activates transcription factors and regulates gene expression through a cascade reaction (MAPKKK-MAPKK-MAPK). MAPK can trigger the activation of transcription factors in the nucleus, participate in the process of signalling from the cell surface to the nucleus, and regulate cell proliferation and differentiation. Currently, there are 4 known MAPK signalling pathways, including the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK, also known as SAPK), p38, and ERK5 pathways.

1.1 ERK-MAPK signalling pathway

In the MAPK signalling pathway, the ERK pathway acts mainly through the Ras-Raf-MEK-ERK cascade. The main process of this pathway: the growth factor activates the receptor by binding to the receptor tyrosine kinase, and the activated receptor tyrosine kinase activates the Ras protein, then the Ras protein phosphorylates Raf, and the activated Raf phosphorylates the MEK waters. below. MEK can phosphorylate and activate ERK, which is transferred to the nucleus and regulates gene expression by activating other kinases or transcription factors.

The ERK-MAPK signalling pathway plays a role in the differentiation of mesenchymal stem cells (MSCs) into adipocytes. In the early stage of adipocyte differentiation, ERK1/2 promotes adipocyte differentiation by promoting the expression of C/EBPα and PPARγ. In the late stage of adipocyte differentiation, activated ERK1/2 phosphorylates PPARγ to inactivate it and inhibit adipocyte differentiation. This pathway can also affect the proliferation and differentiation of red blood cells. Studies have shown that the ERK signalling pathway is also involved in signal transduction of osteoblast differentiation and proliferation.

1.2 Via JNK-SAPK

c-Jun N-terminal kinase (JNK), also known as stress-activated protein kinase (SAPK), is another subclass of MAPK in mammals. The JNK signalling pathway can affect a variety of vital processes, such as cell growth, cell differentiation, and cell death. JNK can change the level of osteocalcin mRNA, thus JNK activation can induce osteoblast differentiation. The JNK signalling pathway also plays an important role in the regulation of adipocyte differentiation.

1.3 via p38 MAPK

The p38 signalling pathway is an important component of the MAPK family. p38 MAPK can be activated by a variety of extracellular stress responses, including ultraviolet rays, radiation, and proinflammatory factors. The p38 pathway plays a very important role in the osteogenic differentiation of mesenchymal stem cells (MSCs). Inhibition of the p38 MARK pathway downregulates the activity of protein kinase C (PKC), which plays an important role in the osteogenic differentiation of cells.

In addition, the transforming growth factor and the bone morphogenetic protein BMP-2 induce the transcriptional expression of Runx2/Cbfa1 through the p38 MAPK pathway. Among them, Runx2 is a key target gene affecting osteogenic activity, and Cbfa1 regulates MSC differentiation into osteoblasts at the transcriptional level.

2. Phosphatidylinositol (PLC) signalling pathway

In the phosphatidylinositol signalling pathway, extracellular signalling molecules bind to G protein-coupled receptors, activating phospholipase C (PLC-β) on the plasma membrane, causing phosphatidylinositol bisphosphate ( PIP2) to be hydrolyzed to inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DG). Therefore, the phosphatidylinositol (PLC) signalling pathway is also called the “dual messenger system”.

IP3 turns on the calcium channel and initiates signals downstream. Ca2+ binds to calmodulin (CaM) to form a Ca2+-CaM complex, which activates adenylate cyclase (AC) and phosphodiesterase (PDE); activates Ca2+-CaM dependent protein kinase. DAG activates PKC, phosphorylates serine/threonine residues of proteins, and produces different cellular responses, such as cell secretion, muscle contraction, cell proliferation and differentiation. The PLC-γ pathway is also involved in the differentiation of red blood cells.

3. cAMP/PKA signalling pathway

Cyclic adenosine monophosphate (cAMP) is an important intracellular signalling molecule, activates cAMP-dependent protein kinase A (PKA), and regulates cell differentiation. cAMP/PKA signalling can promote the adipogenic differentiation of MSCs and inhibit their osteogenic differentiation.

4. Via JAK-STAT

JAK is a tyrosine kinase whose main substrate is the STAT transcription factor. Activated STAT translocates to the nucleus and binds to the DNA sequence, thus regulating gene expression. The JAK-STAT pathway plays an important role in cell proliferation, apoptosis, and differentiation.

The main process of this signal pathway is as follows:

  • The binding of the ligand to the receptor leads to receptor dimerization. Dimerized receptors activate JAK, JAK phosphorylation STAT. Phosphorylated STAT forms dimers that enter the nucleus and bind to DNA sequences to regulate gene expression.
  • The JAK/STAT pathway plays an important role in the proliferation and differentiation of red blood cells.

5. PI3K-AKT-mTOR signalling pathway

The mammalian target of rapamycin (mTOR) is a conserved serine/threonine-protein kinase with two main forms: mTORC1 and mTORC2. Activated mTOR plays a key regulatory role in cell proliferation, differentiation, and metabolism. mTOR is primarily regulated by the PI3K/Akt/mTOR signalling pathway and the LKB1/AMPK/mTOR signalling pathway.

These two signalling pathways are the main pathways that regulate the proliferation and differentiation of testicular support cells. In the mTOR signalling pathway, deletion of the mTOR gene leads to a decrease in the number of testicular support cells. Studies have shown that PI3K-activated Akt kinase plays an important role in hematopoiesis. The PI3K pathway is also important in small intestinal stem cell regeneration and in promoting cell differentiation.

6. Wnt signalling pathway

The Wnt signalling pathway is highly conserved and the central component of this signalling pathway is β-catenin. When the Wnt signal is not activated, intracellular β-catenin is phosphorylated and degraded by the proteasome. When the Wnt protein binds to its receptor Frizzled and LRP, the β-catenin degradation complex is inactivated, β-catenin is released and accumulates in the cell. Accumulated β-catenin enters the nucleus and binds to transcription factor and T-cell factor/lymphocyte-enhancing factor (TCF/LEF) to initiate a series of proliferation-related genes.

6.1 Wnt signalling pathway and adipocyte differentiation

Activation of the Wnt signalling pathway can inhibit fat cell differentiation, and once this pathway is out of control, obesity can occur. The Wnt signalling pathway is activated by interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α), which inhibits β-catenin degradation. β-catenin further inhibits downstream levels of C/EBP and PPAR, impairing or even preventing adipocyte differentiation.

Fat cell differentiation was also affected by the PPAR signalling pathway and the Hedgehog signalling pathway. The PPAR family plays an important role in fat differentiation and metabolism. Among them, PPARγ, as an important transcription factor for adipogenic differentiation, can accelerate adipocyte differentiation and deposition.

6.2 Wnt signalling pathway and cartilage differentiation

Activation of the Wnt signalling pathway can promote chondrocyte differentiation. During chondrogenic differentiation, the Wnt signalling pathway acts in conjunction with many other pathways. In cartilage differentiation, TGF-β and Wnt signalling pathways together promote cartilage differentiation from mesenchymal stem cells. In addition, the Wnt signalling pathway can promote small intestinal stem cell differentiation and cardiomyocyte differentiation, and promote the proliferation and differentiation of testicular support cells.

7. TGF-β Superfamily Signaling Pathway

The TGF-β superfamily regulates cell growth, proliferation, differentiation, migration, and apoptosis, regulates embryonic development, participates in the body’s immune response, and has multifunctional biological activities. The TGF-β signalling pathway affects the proliferation and differentiation of testicular support cells.

Cusabio Equus caballus Recombinant

Cusabio Equus caballus Recombinant

Summary

The interspersed repeat content of mammalian genomes has been best characterized in humans, mice, and cows. In this study, we carried out a de novo identification of repeated elements in the equine genome and identified previously unknown elements present at low copy numbers. The equine genome contains repeats typical of eutherian mammals but also has a significant number of hybrid repeats in addition to clade-specific long interspersed nuclear elements (LINEs).

The clade-specific LINE 1 (L1) repeats of Equus caballus Recombinant can be classified into approximately five subfamilies, three of which have undergone significant expansion. There are 1115 complete copies of this equine L1s, but of the 103 presumed active copies, 93 belong to a single subfamily, indicating a recent rapid expansion of this subfamily. We also analyzed both genome-wide simple sequence repeats (SSRs) and interspersed ones, finding that some repeat classes are spatially correlated with each other, as well as with G+C content and gene density.

On the basis of these spatial correlations, we have confirmed that recently described clade-specific versus ancestral genome territories can be defined by their repeat content. Correlations of clade-specific short interspersed nuclear elements were scattered throughout the genome and appear to have been extensively remodelled. In contrast, territories enriched by ancestral repetitions tended to be contiguous domains.

To determine whether these latter territories were evolutionarily conserved, we compared these results with a similar analysis of the human genome and observed enriched domains with similar ancestral repeats. These results indicate that evolutionarily conserved territories of the ancestral mammalian genome can be identified on the basis of repeat content alone. Interspersed repeats of different ages appear to be analogous to geological strata, allowing identification of ancient versus newly remodelled regions of mammalian genomes.

Purity: >85% (SDS-PAGE)

Target names: INS

Uniprot No.: P01310

Alternative Names: SIN; Insulin [Split into insulin B chain; insulin A chain]

Species: Equus caballus (Horse)

Expression Region: 1-30

Protein Length: Cytoplasmic Domain

Label information

The following labels are available.

  • N-terminus His-tagged
  • Without tags
  • The type of label will be determined during the production process. If you have specified a tag type, let us know and we will develop the specified tag preferentially.

Form: Lyophilized powder

Buffer before lyophilization: Tris/PBS based buffer, 6% trehalose, pH 8.0

Reconstitution

We recommend that this vial be briefly centrifuged before opening to bring the contents to the bottom. Reconstitute protein in sterile deionized water at a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and an aliquot for long-term storage at -20℃/-80℃. Our final default glycerol concentration is 50%. Customers could use it for reference.

Storage Conditions

Store at -20°C/-80°C upon receipt, need to be aliquoted for multiple uses. Avoid repeated cycles of freezing and thawing.

Shelf life

Shelf life is related to many factors, storage condition, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.

Delivery time

The delivery time may differ depending on the way or location of purchase, consult your local distributors for the specific delivery time.

Note: All of our proteins are shipped with regular blue ice packs by default. If you request shipping with dry ice, please contact us in advance and additional fees will be charged.

Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

[Prospects for molecular-genetic support of research on proteolytics in the necrobiome composition]

[Prospects for molecular-genetic support of research on proteolytics in the necrobiome composition]

The purpose of this work is to watch the state of the proteolytic group in time and house for the subsequent growth of approaches to an goal evaluation of the late postmortem interval. The examine proposes a mixture of customary bacterioscopic and bacteriological research strategies with strategies of molecular biology and genetics, which make it attainable to establish species and strains of mammalian corpses’ proteolytics at the degree of particular DNA or RNA. On the foundation of phenotypic traits and a comparative evaluation of the nucleotide sequences of genes encoding 16S rRNA, the species belonging of the remoted strains was proved.

The set of strategies’ mixture, together with conventional microbiological evaluation and molecular genetic research, appears promising each for the objective of substantiating and widespread use of microbiological strategies in forensic medical observe, and for growth an goal scientific base for establishing the cause-and-effect patterns of microbial transformation of natural matter in nature.Self-fertilization (additionally termed selfing) is a mode of replica that happens in hermaphrodites and has advanced a number of occasions in varied plant and animal species. A transition from outbreeding to selfing in hermaphroditic flowers is often related to modifications in flower morphology and performance.

This examine aimed to establish genetic results of selfing in the F2 progeny of F1 hybrid developed by crossing Lilium lancifolium with the Asiatic Lilium hybrid ‘Dreamland.’ Fluorescence in situ hybridization (FISH) and inter-simple sequence repeats (ISSR) methods have been used to detect genetic variations in crops produced by selfing. The FISH outcomes confirmed that F1 hybrid have been much like the feminine guardian (L. lancifolium) concerning the 45S loci, however F2 people confirmed variation in the quantity and placement of the respective loci. In F2 progeny, F2-2, F2-3, F2-4, F2-5, and F2-Eight hybrids expressed two robust and one weak 5S sign on chromosome 3, whereas F2-7 and F2-9 people expressed one robust and two weak alerts.

Only two robust 5S alerts have been detected in an F2-1 plant. The ISSR outcomes confirmed a most similarity worth of 0.6269 between the feminine guardian and the F2-2 hybrid. Regarding similarity to the male guardian, a most worth of 0.6119 was discovered in the F2-1 and F2-2 hybrids. The highest genetic distance from L. lancifolium and the Asiatic Lilium hybrid ‘Dreamland’ was noticed in the F2-Four progeny (0.6352 and 0.7547, respectively). Phylogenetic relationships confirmed that the F2 progeny have been nearer to the male guardian than to the feminine guardian. Self-fertilization confirmed results on variation amongst the F2 progeny, and results on the genome have been confirmed utilizing FISH and ISSR analyses.

Genetic and molecular biology of autism spectrum dysfunction amongst Middle East inhabitants: a assessment

Autism spectrum dysfunction (ASD) is a neurodevelopmental illness, characterised by impaired social communication, govt dysfunction, and irregular perceptual processing. It is extra frequent amongst males. All of these scientific manifestations are related to atypical neural growth. Various genetic and environmental danger components are concerned in the etiology of autism. Genetic evaluation is crucial for the early detection and intervention which might enhance social communications and scale back irregular behaviors. We have additionally categorized the reported genes based mostly on their cell and molecular features.
Although, there’s a noticeable ASD incidence in Middle East nations, there may be nonetheless a scarcity of information about the genetic and molecular biology of ASD amongst this inhabitants to introduce environment friendly diagnostic and prognostic strategies. In the current assessment, we have now summarized all of the genes which have been related to ASD development amongst Middle East inhabitants.  This assessment clarifies the genetic and molecular biology of ASD amongst Middle East inhabitants and paves the means of introducing an environment friendly inhabitants based mostly panel of genetic markers for the early detection and administration of ASD in Middle East nations.
[Prospects for molecular-genetic support of research on proteolytics in the necrobiome composition]

From mutation to mechanism: deciphering the molecular perform of genetic variants linked to human ageing

Many of the main causes of dying in people, equivalent to heart problems, kind 2 diabetes and Alzheimer’s illness are influenced by organic mechanisms that turn into dysregulated with growing age. Hence, by focusing on these ageing-related mechanisms, we might be able to enhance well being in outdated age. Ageing is partly heritable and genetic research have been reasonably profitable in figuring out genetic variants related to ageing-related phenotypes (lifespan, healthspan and longevity). To decipher the mechanisms by which the recognized variants affect ageing, research that focus on their useful validation are very important.

In this angle, we describe the steps that may very well be taken in the course of of useful validation: (1) in silico characterisation utilizing bioinformatic instruments; (2) in vitro characterisation utilizing cell strains or organoids; and (3) in vivo characterisation research utilizing mannequin organisms. For the in vivo characterisation, you will need to focus on translational phenotypes which are indicative of each healthspan and lifespan, equivalent to the frailty index, to tell subsequent intervention research. The depth of useful validation of a genetic variant relies upon on its location in the genome and conservation in mannequin organisms.

Moreover, some variants could show to be exhausting to characterise attributable to context-dependent results associated to the experimental setting or genetic background. Future efforts to functionally characterise the (newly) recognized genetic variants ought to shed mild on the mechanisms underlying ageing and can assist in the design of focused interventions to enhance well being in outdated age.

Antigenic and Molecular Characterization of Low Pathogenic Avian Influenza A(H9N2) Viruses in Sub-Saharan Africa from 2017 through 2019

Antigenic and Molecular Characterization of Low Pathogenic Avian Influenza A(H9N2) Viruses in Sub-Saharan Africa from 2017 through 2019

Sub-Saharan Africa was traditionally thought-about an animal influenza chilly spot, with solely sporadic extremely pathogenic H5 outbreaks detected over the past 20 years. However, in 2017, low pathogenic avian influenza A(H9N2) viruses had been detected in poultry in Sub-Saharan Africa. Molecular, phylogenetic, and antigenic characterization of isolates from Benin, Togo, and Uganda confirmed that they belonged to the G1 lineage. Isolates from Benin and Togo clustered with viruses beforehand described in Western Africa, whereas viruses from Uganda had been genetically distant and clustered with viruses from the Middle East. Viruses from Benin exhibited decreased cross-reactivity with these from Togo and Uganda, suggesting antigenic drift related to diminished replication in Calu-Three cells.

The viruses exhibited mammalian adaptation markers just like these of the human strainCigarette smoking is a serious threat issue for lung most cancers improvement and development; nevertheless, the mechanism of how cigarette smoke prompts signaling pathways in selling most cancers malignancy stays to be established. Herein, we aimed to find out the contribution of a signaling protein, myristoylated alanine-rich C kinase substrate (MARCKS), in smoke-mediated lung most cancers. We firstly examined the degrees of phosphorylated MARCKS (phospho-MARCKS) in smoke-exposed human lung most cancers cells and specimens in addition to non-human primate airway epithelium.

Next, the MARCKS-interactome and its gene networks had been recognized. We additionally used genetic and pharmacological approaches to confirm the performance and molecular mechanism of smoke-induced phospho-MARCKS. We noticed that MARCKS turns into activated in airway epithelium and lung most cancers cells in response to cigarette smoke. Functional proteomics revealed MARCKS protein instantly binds to NF-κB-activating protein (NKAP). Following MARCKS phosphorylation at ser159 and ser163, the MARCKS-NKAP interplay was inhibited, resulting in the activation of NF-κB signaling.

In a display of two cohorts of lung most cancers sufferers, we confirmed that phospho-MARCKS is positively correlated with phospho-NF-κB (phospho-p65), and poor survival. Surprisingly, smoke-induced phospho-MARCKS upregulated the expression of pro-inflammatory cytokines, epithelial-mesenchymal transition, and stem-like properties. Conversely, focusing on of MARCKS phosphorylation with MPS peptide, a selected MARCKS phosphorylation inhibitor, suppressed smoke-mediated NF-κB signaling exercise, pro-inflammatory cytokines expression, aggressiveness and stemness of lung most cancers cells. Our outcomes recommend that phospho-MARCKS is a novel NF-kB activator in smoke-mediated lung most cancers development and present a promising molecular mannequin for growing new anticancer methods.

Rapid choice response to ethanol in Saccharomyces eubayanus emulates the domestication course of beneath brewing circumstances

Although the everyday genomic and phenotypic adjustments that characterize the evolution of organisms beneath the human domestication syndrome symbolize textbook examples of fast evolution, the molecular processes that underpin such adjustments are nonetheless poorly understood. Domesticated yeasts for brewing, the place quick technology instances and giant phenotypic and genomic plasticity had been attained in just a few generations beneath choice, are prime examples. To experimentally emulate the lager yeast domestication course of, we created a genetically advanced (panmictic) synthetic inhabitants of a number of Saccharomyces eubayanus genotypes, one of the mother and father of lager yeast.

Then, we imposed a relentless choice regime beneath a excessive ethanol focus in 10 replicated populations throughout 260 generations (6 months) and in contrast them with propagated controls uncovered solely to glucose. Propagated populations exhibited a variety differential of 60% in progress fee in ethanol, largely defined by the proliferation of a single lineage (CL248.1) that competitively displaced all different clones. Interestingly, the result doesn’t require your complete time-course of adaptation, as 4 lineages monopolized the tradition at technology 120. Sequencing demonstrated that de novo genetic variants had been produced in all propagated strains, together with SNPs, aneuploidies, INDELs and translocations.

In addition, the completely different propagated populations confirmed correlated responses resembling the domestication syndrome: genomic rearrangements, quicker fermentation charges, decrease manufacturing of phenolic off-flavours and decrease unstable compound complexity. Expression profiling in beer wort revealed altered expression ranges of genes associated to methionine metabolism, flocculation, stress tolerance and diauxic shift, doubtless contributing to increased ethanol and fermentation stress tolerance in the advanced populations. Our examine reveals that experimental evolution can rebuild the brewing domestication course of in ‘quick movement’ in wild yeast, and additionally gives a robust software for learning the genetics of the variation course of in advanced populations.

Antigenic and Molecular Characterization of Low Pathogenic Avian Influenza A(H9N2) Viruses in Sub-Saharan Africa from 2017 through 2019

The mitogenome of Ophidascaris wangi remoted from snakes in China

Different species of the genus Ophidascaris (Baylis, 1921; Nematoda: Ascaridida, Ascaridoidea) are intestinal parasites of varied snake species. More than 30 Ophidascaris species have been reported worldwide; nevertheless, few molecular genetic research have been performed on this genus. We sequenced the whole mitogenome of Ophidascaris wangi parasitizing two snake species of the household Colubridae, i.e., Elaphe carinata (Günther, 1864) and Dinodon rufozonatum. The mitogenome sequence of O. wangi was roughly 14,660 base pairs (bp) lengthy and encoded 36 genes, together with 12 protein-coding genes (PCGs), 2 ribosomal RNA (rRNA) genes, and 22 switch RNA genes.

Gene association, genome content material, and transcription route had been in line with these in Toxascaris leonina (Linstow, 1902; Ascaridida: Ascarididae). Phylogenetics of O. wangi and different ascaridoids had been reconstructed based mostly on the concatenated amino acid sequences of 12 PCGs, and on nucleotide sequences of 12 PCGs and two rRNA genes. Phylogenetic analyses had been carried out utilizing most probability and Bayesian inference strategies, and the outcomes prompt that O. wangi constitutes a sister clade of Ascaris, Parascaris, Baylisascaris, and Toxascaris inside the household Ascarididae, which is a sister clade of Toxocaridae.

Silica Gel 400-700 mesh

36834 500 Gms
EUR 5.41
Description: Part A

Silica Gel 200-400 mesh

63025 500 Gms
EUR 3.83
Description: Part A

Silica Gel Grade 03 8 Mesh

S02570 1KG
EUR 85.3
Description: CAS N° 7631-86-9

Silica Gel Grade 408 12-24 Mesh

S02577 500G
EUR 219.6
Description: CAS N° 7631-86-9

Silica Gel 60

30721-01 1KG
EUR 81.9

Silica Gel 60

30721-14 5KG
EUR 298.9

Silica Gel 60

30721-85 500G
EUR 49

Silica Gel 60

30724-55 500G
EUR 27.3

Silica Gel 60

30724-71 1KG
EUR 49.7

Silica Gel 60

30724-84 5KG
EUR 205.1

Silica Gel Grade 40 -6+12 Mesh (1680-3350 microns)

S02572 250G
EUR 119.2
Description: CAS N° 7631-86-9

Silica Gel 120, spherical

30734-41 1KG
EUR 56.7

Silica Gel Blue (Self Indicating) (Coarse), 5-8 mesh

85148 500 Gms
EUR 3.63
Description: Part A

Silica Gel 60, spherical

30731-42 25KG
EUR 957.6

Silica Gel 60, spherical

30731-71 1KG
EUR 51.8

Silica Gel 60, spherical, neutral

30511-06 5KG
EUR 343

Silica Gel 60, spherical, neutral

30511-22 25KG
EUR 1540

Silica Gel 60, spherical, neutral

30511-35 500G
EUR 57.4

Silica Gel 60, spherical, neutral

30511-51 1KG
EUR 98

Silica Gel 60, spherical, neutral

30511-64 100G
EUR 21

Silica Gel 60, spherical, neutral

30518-65 500G
EUR 42

Silica Gel 60, spherical, neutral

30518-81 1KG
EUR 66.5

Silica Gel 60, spherical, neutral

30518-94 100G
EUR 17.5

Silica Gel

30615-85 500G
EUR 19.6

Silica Gel

30619-45 500G
EUR 19.6

Silica Gel

17091-55 500G
EUR 12.25

Silica Gel

17092-45 500G
EUR 19.6

Silica Gel G for TLC, 325mesh, w/ CaSO4

51849 500 Gms
EUR 3.69
Description: Part A

Silica Gel H for TLC, 325mesh, w/o CaSO4

52797 500 Gms
EUR 3.69
Description: Part A

Drying Reagent, Silica Gel

DSG110 1Kg
EUR 91.32

Color-Changing Silica Gel

S9951
  • Ask for price
  • Ask for price
  • 500 g
  • 1 Kg

Silica Gel GF254 for TLC, 325mesh, w/ Fluorescent Indicator w/ CaSO4

38062 500 Gms
EUR 26.68
Description: Part A

Silica Gel HF254 for TLC, 325mesh, w/ Fluorescent Indicator w/o CaSO4

29774 500 Gms
EUR 26.68
Description: Part A

Silica Gel with 3% AgNO3

S450270 10g
EUR 800

Silica Gel Fumed 200 (Hydrophilic)

84210 100 Gms
EUR 3.22
Description: Part A

Silica Gel, 40-63 Micron Particles

S450200 1kg
EUR 787
Description: 112926-00-8

Silica Gel, 35-70 Micron Particles

S450400 2.5kg
EUR 667
Description: 112926-00-6

Silica gel orange 360 g - EACH

DD490938 EACH
EUR 87.75

Silica Gel Large Pore 70 microns

S02580 100G
EUR 102.24
Description: CAS N° 1343-98-2

Silica Gel In Bag, 5G, 100/Pk

DSG111 1PK, 100UNIT
EUR 73.57

Silica Gel Grade 12 High Purity Chromatographic Gel 28-20

S02571 1KG
EUR 140.95
Description: CAS N° 112945-52-5

5g Silica Gel Sachets In Tyvek - PK1000

X17976 PK1000
EUR 130.72

Silica Gel Orange (Self Indicating), 2-5mm

71548 500 Gms
EUR 4.11
Description: Part A

3-Aminopropyl-funtionalized Silica Gel (40-63 μm)

A450215 1g
EUR 132

Silica gel with moisture indicator (Reagent grade)

ST2636-1kg 1 Kg Ask for price

Silica Gel Grade 923 High Purity Chromatographic_x000D_

S02578 100G
EUR 239.23
Description: CAS N° 7631-86-9

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287 500g
EUR 159.23

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287-1 1
EUR 47.4

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287-1KG 1 kg
EUR 93.6

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287-5 5
EUR 174

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287-500 500
EUR 27.8

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287-500G 500 g
EUR 69.6

Silica Gel, pore size ~25A, 1 - 3 mm beads

GX9287-5KG 5 kg
EUR 246

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254 500g
EUR 159.23

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254-1 1
EUR 47.4

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254-1KG 1 kg
EUR 93.6

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254-5 5
EUR 174

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254-500 500
EUR 27.8

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254-500G 500 g
EUR 69.6

Silica Gel, pore size ~25A, 2 - 5 mm beads

GX6254-5KG 5 kg
EUR 246

C18 Silica Gel (>10% C-18; Capped With TMS)

S452500 50g
EUR 265

Silica gel, pore size 60A, particle size 40-63 micron

GX9977 1kg
EUR 49.79

Silica gel, pore size 60A, particle size 40-63 micron

GX9977-1 1
EUR 54.4

Silica gel, pore size 60A, particle size 40-63 micron

GX9977-1KG 1 kg
EUR 102

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162 500g
EUR 195.68

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162-1 1
EUR 58.4

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162-1KG 1 kg
EUR 106.8

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162-5 5
EUR 213.7

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162-500 500
EUR 33.1

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162-500G 500 g
EUR 76.8

Silica Gel, self-indicating, blue to pink, 2 - 5 mm beads

GE5162-5KG 5 kg
EUR 294

Silica Gel, self-indicating, orange to green, 2 - 5 mm beads

GE5612 500g
EUR 208.67

Silicon powder 99.999% -325 Mesh

S02610 25G
EUR 352.06
Description: CAS N° 7440-21-3

DiagNano™ SBA-15 Mesoporous Silica Particles, 100 μm, 120 A Pore Size

DNG-GS383 5 g
EUR 768

Silicon carbide 99% -100 Mesh

S02620 500G
EUR 180
Description: CAS N° 409-21-2

Silicon dioxide 99.5% -325 MESH

S02645 250G
EUR 137.4
Description: CAS N° 7631-86-9

Silicon(IV) oxide, 99.99%, -100 mesh

GX8518 50g
EUR 406.18

Silicon(IV) oxide, 99.99%, -100 mesh

GX8518-250 250
EUR 356.8

Silicon(IV) oxide, 99.99%, -100 mesh

GX8518-50 50
EUR 140.2

DiagNano™ SBA-15 Mesoporous Silica Particles, 100 μm, 60 A Pore Size

DNG-GS380 5 g
EUR 768

DiagNano™ SBA-16 Mesoporous Silica Particles, 10 μm, 60 A Pore Size

DNG-GS384 5 g
EUR 768

DiagNano™ Amine SBA-15 Mesoporous Silica Particles, 100 μm, 120 A Pore Size

DNG-GS391 5 g
EUR 928

DiagNano™ Thiol SBA-15 Mesoporous Silica Particles, 100 μm, 120 A Pore Size

DNG-GS397 5 g
EUR 928

Silica Gel, self-indicating, orange to colourless, 4 - 8 mm beads, cobalt free

GE9411 500g
EUR 55.02

Silica Gel, self-indicating, orange to colourless, 4 - 8 mm beads, cobalt free

GE9411-1 1
EUR 60.1

Silica Gel, self-indicating, orange to colourless, 4 - 8 mm beads, cobalt free

GE9411-1KG 1 kg
EUR 109.2

Silica Gel, self-indicating, orange to colourless, 4 - 8 mm beads, cobalt free

GE9411-500 500
EUR 35.5

Silica Gel, self-indicating, orange to colourless, 4 - 8 mm beads, cobalt free

GE9411-500G 500 g
EUR 79.2

Silicon Metal powder, 98.5%, -200 mesh

73081 100 Gms
EUR 2.4
Description: Part B

Silicon nitride -325 or -2500 mesh sizes

S02660 10G
EUR 139.5
Description: CAS N° 12033-89-5

DiagNano™ Amine SBA-15 Mesoporous Silica Particles, 100 μm, 60 A Pore Size

DNG-GS388 5 g
EUR 928

DiagNano™ Amine SBA-16 Mesoporous Silica Particles, 10 μm, 60 A Pore Size

DNG-GS392 5 g
EUR 928

DiagNano™ Thiol SBA-15 Mesoporous Silica Particles, 100 μm, 60 A Pore Size

DNG-GS394 5 g
EUR 928

DiagNano™ Thiol SBA-16 Mesoporous Silica Particles, 10 μm, 60 A Pore Size

DNG-GS398 5 g
EUR 928

Silicon Powder -100, +325 mesh, amorphous, 99.999%

GX3061 50g
EUR 973.41

Silicon Powder -100, +325 mesh, amorphous, 99.999%

GX3061-250 250
EUR 840.8

Silicon Powder -100, +325 mesh, amorphous, 99.999%

GX3061-50 50
EUR 236.2

Silicon Metal powder, 98.5%, -4 mesh

79427 500 Gms
EUR 9.75
Description: Part B

DiagNano™ SBA-15 Mesoporous Silica Particles, 100 μm, 60 A Pore Size, Pellets

DNG-GS385 5 g
EUR 928

Silica

si300 2 ML
EUR 367.5

Florisil, 60 - 100 mesh

GE3010 100g
EUR 76.04

Florisil, 60 - 100 mesh

GE3010-100 100
EUR 39.4

Florisil, 60 - 100 mesh

GE3010-100G 100 g
EUR 84

Florisil, 60 - 100 mesh

GE3010-250 250
EUR 83.1

Florisil, 60 - 100 mesh

GE3010-250G 250 g
EUR 136.8

Florisil, 30 - 60 mesh

GX7568 500g
EUR 131.67

Zeolite - Mesoporous Silica Molecular Sieve Kit-6

65276 1 Gms
EUR 124.34
Description: Part C

Zeolite - Mesoporous Silica Nanopowder (SBA-15 Type)

83881 250 Mg
EUR 31.09
Description: Part C

Zeolite - Mesoporous Silica Nanopowder (SBA-15 Type)

83881-1 1 Gms
EUR 93.55
Description: Part C

Monodisperse Mesoporous Silica Nanosphere Stellate MSN

NM000860
  • Ask for price
  • Ask for price
  • 1 g
  • 5 g

Strontium nitride -60 mesh

S09696 1G
EUR 225.94
Description: CAS N° 12033-82-8

DiagNano™ PEI Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN27 5 mL
EUR 1280

DiagNano™ PEI Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN45 5 mL
EUR 1280

DiagNano™ Carboxyl Mesoporous Silica Particles, 3 μm

DNG-C046 10 mL
EUR 1020

DiagNano™ Plain Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN23 5 mL
EUR 928

DiagNano™ Amine Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN25 5 mL
EUR 976

DiagNano™ Thiol Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN29 5 mL
EUR 1280

DiagNano™ Plain Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN41 5 mL
EUR 928

DiagNano™ Amine Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN43 5 mL
EUR 976

DiagNano™ Thiol Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN47 5 mL
EUR 1280

DiagNano™ S-S Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN28 5 mL
EUR 1280

DiagNano™ S-S Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN46 5 mL
EUR 1280

Amorphous silica

HY-154739A Get quote Ask for price
Description: Amorphous silica can be used as an excipient, such as viscosifier, suspending agent, tablet disintegrating agent, adsorbent dispersing agent as liquid in powders. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1].

Colloidal silica

S5070 25 g Ask for price

DiagNano™ Carboxyl Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN24 5 mL
EUR 976

DiagNano™ Carboxyl Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN42 5 mL
EUR 976

Flash Silica 120g - PK5

CHR5204 PK5
EUR 152.55

Flash Silica 330g - EACH

CHR5208 EACH
EUR 124.2

Cesium carbonate, 60 - 80 mesh

abx185375-500g 500 g
EUR 427.2

Manganese Powder -60 mesh, 99.98%

GX4231 50g
EUR 260.55

Manganese Powder -60 mesh, 99.98%

GX4231-50 50
EUR 210.1

Zeolite - Mesoporous Silica Nanopowder (3D-Cubic MCM-48 Type)

63876 250 Mg
EUR 143.88
Description: Part C

Zeolite - Mesoporous Silica Nanopowder (3D-Cubic MCM-48 Type)

63876-1 500 Mg
EUR 210.99
Description: Part C

DiagNano™ PEG Carboxyl Mesoporous Silica Nanoparticles, 50 nm

WHM-23DN26 5 mL
EUR 1280

DiagNano™ PEG Carboxyl Mesoporous Silica Nanoparticles, 100 nm

WHM-23DN44 5 mL
EUR 1280

Zeolite - Mesoporous Silica Nanopowder (1D-Hexagonal SBA-41 Type)

97621 250 Mg
EUR 143.88
Description: Part C

Zeolite - Mesoporous Silica Nanopowder (1D-Hexagonal SBA-41 Type)

97621-1 500 Mg
EUR 210.99
Description: Part C

The mitogenome sequence of O. wangi obtained from the current examine will probably be helpful for future identification of the nematode worms in the genus Ophidascaris and will enhance the understanding of inhabitants geneticsmolecular epidemiology, and phylogenetics of ascaridoid nematodes in snakes.